A Decent CAGR to Define Carcinoid Tumor Market in the Forecast Period

Uwagi · 204 Wyświetlenia

Shining a Light on Hope: Unveiling the Latest Breakthroughs in Carcinoid Tumor Market Learn More

Carcinoid Tumor Market Highlights

The Carcinoid Tumor Market was estimated at USD 1.2 billion in 2022. During the time frame of the projection (2023 - 2032), the carcinoid tumor market sector is anticipated to surge from USD 1.32 billion in 2023 to USD 2.947 billion by 2032 at a compound annual growth rate (CAGR) of 10.50%.

Carcinoid tumor is a type of the neuroendocrine tumor. The most common site of carcinoid tumors is the GI (gastrointestinal) tract and the lungs. However, it can also be developed in pancreas, testicles, and ovaries. The increasing prevalence of the carcinoid tumor is expected to drive the market growth. According to the American Society of Clinical Oncology (ASCO), approximately 8,000 adults in the US were diagnosed with a carcinoid tumor in their GI tract. Moreover, it was also estimated that each year approximately 4,000 adults in the US are diagnosed with a carcinoid tumor in their lung. Moreover, growing geriatric population along with rising healthcare expenditure is likely to boost the market growth during the forecast period. However, lack of awareness, high treatment cost and related side effects may hamper the market growth during the forecast period. 

Segmentation

The global carcinoid tumor market is segmented on the basis of site, diagnosis, treatment, and end users.

On the basis of the site, the market is segmented into gastrointestinal, lung, and others. Furthermore, the gastrointestinal segment is sub-segmented into rectum, small intestine, appendix, and others. Lung segment is sub-segmented into typical, atypical, and others.

On the basis of the diagnosis, the market is segmented into serology, imaging, biopsy, and others. The serology segment is sub-segmented into blood test, urine test, molecular test, and others. The imaging segment is sub-segmented into X-ray, CT scan, PET scan, and others.

On the basis of the treatment, the market is segmented into surgery, chemotherapy, radiotherapy, and others. The surgery segment is sub-segmented into local excision, radiofrequency ablation (RFA), and others.

On the basis of the end users, the market is segmented into hospitals & clinics, academic institutes, research organization, and others.

Regional Analysis

America dominates the global carcinoid tumor market owing to a well-developed healthcare sector and huge patient population. Apart from this, increasing healthcare expenditure and presence of developed economies like the U.S. and Canada within the region have boosted the growth of the market in America.

Europe is the second leading market across the globe, which is followed by Asia Pacific owing to availability of funds for research, huge patient population, and strong government support for research & development. 

Asia Pacific is the fastest growing region in the market due to the presence of a huge patient population and continuously developing economies like India and China, which have rising healthcare expenditure. Moreover, favorable governmental policies and the presence of huge opportunity in the untapped market within the region are likely to fuels the market growth during the forecast period. 

On the other hand, the Middle East & Africa holds the least share in the global carcinoid tumor market due to presence of poor economy, especially, in Africa region. Majority of the market of this region is held by the Middle East due to a well-developed healthcare sector and huge healthcare expenditure. The presence of developed economies like Qatar, Saudi Arabia, Dubai, and others within the region fuels the market growth.

Key Players

Some of the top key carcinoid tumor market players are Novartis AG (Europe), Amgen Inc. (U.S.), Boehringer Ingelheim GmbH (Europe), AVEO Pharmaceuticals, Inc. (U.S.), Chiasma, Inc. (U.S.), Aegis Therapeutics, LLC (U.S.), CRINETICS PHARMACEUTICALS (U.S.), Delcath Systems Inc. (U.S.), Exelixis, Inc. (U.S.), and others.

About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Contact Us:

Market Research Future (Part of Wantstats Research and Media Private Limited)

99 Hudson Street, 5Th Floor

New York, NY 10013

United States of America

+1 628 258 0071 (US)

+44 2035 002 764 (UK)

Email: sales@marketresearchfuture.com

Website: https://www.marketresearchfuture.com

Uwagi